Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism

Human Genetics

Volumn 105, Issue 6, 1999, Pages 564-566

  Tachezy, Ruth ^a   Mikyšková, Iva ^a   Saláková, Martina ^a   Van Ranst, Marc ^b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ONCOPROTEIN; PROLINE; PROTEIN P53; UBIQUITIN;

ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; CZECH REPUBLIC; EXON; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; WART VIRUS;

CANCER VIRUS; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 17644449549     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004399900138     Document Type: Article

References (15)

1. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM (1991) Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477
2. Beckman G, Birgander R, Själander A, Saha N, Holmberg PA, Kivelä A, Beckman L (1994) Is p53 polymorphism maintained by natural selection. Hum Hered 44:266-270
3. Hall PA, Lane DP (1994) Genetics of growth arrest and cell death: key determinants of tissue homeostasis. Eur J Cancer 13:2001-2012
4. Hartl DL, Clark AG (1997) Principles of population genetics. Sinauer Associates, Sunderland
5. Lanham S, Campbell I, Watt P, Gornall R (1998) p53 polymorphism and risk of cervical cancer. Lancet 352:1631
6. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7:961-963
7. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
8. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y, Nakamura Y (1998) No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 58:4585-4586
9. Schoonjans F, Zalata A, Depuydt CE (1995) MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 48:257-262
10. Själander A, Birgander R, Kivelä A, Beckman G (1995) p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 45:144-149
11. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998a) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229-234
12. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Mathlashewski G, Banks L (1998b) p53 polymorphism and risk of cervical cancer. Nature 396:532
13. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ (1998) p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352:871-872
14. Tachezy R, Hamšíková E, Hájek T, Mikyšková I, Šmahel M, Van Ranst M, Kaňka J, Havránková A, Rob L, Guttner V, Slavík V, Anton M, Kratochvíl B, Kotršová L, Vonka V (1999) Human papillomavirus genotype-spectrum in Czech women and correlation of HPV presence with antibodies against HPV-16, -18, -33 virus-like particles. J Med Virol 58:378-386
15. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092-1100